
Accreditation & QA · 6 min read
ISO/IEC 17025 and A2LA: What Pharmacy QA Should Verify Before Trusting a Lab
Learn what ISO/IEC 17025 accreditation really means for pharmaceutical contract testing, how to read an A2LA scope, and which accreditation questions compounding and 503B quality teams should ask before vendor approval.
Updated September 16, 2026
Accreditation is evidence—not a halo
When a contract testing laboratory says it is “ISO 17025 accredited,” pharmacy quality teams hear reassurance. That is fair—ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. But accreditation is only as useful as the scope behind it.
Two labs can both be accredited and still be unequal partners for USP sterility, endotoxin, or potency work. This guide explains how to verify what accreditation actually covers, with a focus on A2LA scopes commonly seen in U.S. biological / pharmaceutical testing.
ISO/IEC 17025 in one paragraph
ISO/IEC 17025 requires a lab to operate a management system and to demonstrate technical competence for specific activities. Assessors evaluate people, methods, equipment, environment, sampling (when relevant), and reporting—against a defined scope. Accreditation bodies that are ILAC MRA signatories (A2LA is one example) make mutual recognition of accredited results more practical across markets.
For pharmacies, the practical takeaway is: competence is scoped, not global.
A2LA certificates vs marketing badges
A2LA publishes searchable directory information and scope documents. When a lab claims A2LA accreditation:
- Ask for the certificate number and current scope PDF
- Confirm the legal entity / site address matches the lab you will ship to
- Confirm the test method family you need appears on the scope
- Check the expiration / renewal status
- Save the documents in your vendor qualification file
A logo on a website is not vendor qualification. A current scope PDF is.
How to read a scope without getting lost
Scopes vary in format, but you are hunting for:
- Discipline (biological, chemical, mechanical, etc.)
- Test / method descriptions that match your USP chapters or equivalent methods
- Matrices (pharmaceutical products, water, environmental samples, medical devices)
- Site-specific listings if the organization has multiple locations
Watch for mismatches:
- Accredited for food microbiology but being sold as a sterile compounding partner
- Chemistry scope without the chromatographic techniques your potency method needs
- Calibration accreditation presented as if it covers finished-product testing
If the scope language is ambiguous, ask the lab to map your exact USP chapter to line items on the scope—in writing.
Accreditation is not the same as FDA approval of your product
A common confusion in vendor meetings:
- FDA registration of a facility ≠ method validation for your product
- ISO 17025 accreditation ≠ automatic suitability for every matrix
- cGMP claims should be supported by quality system evidence relevant to the work
Your quality agreement should still require method suitability, change control notifications, and investigation communication—even with a pristine accreditation portfolio.
What pharmacy QA should put in the vendor file
Minimum pack for a CTL used in release or critical monitoring:
- Current ISO/IEC 17025 certificate + scope
- Accreditation body identity (A2LA or other ILAC MRA signatory)
- Quality agreement / MSA
- Sample CoA and investigation SOP outline
- Shipping / accessioning instructions
- Evidence of relevant method experience
- Contact tree for urgent failures
For higher-risk sterile release testing, many teams also review recent inspection history discussions (without treating Form 483 lore as internet gossip—ask the lab directly for how they handle regulatory interactions).
Questions that separate serious labs from brochure labs
Use these on qualification calls:
- Which scope line items cover the USP chapters we need?
- Which physical site will receive our samples, and is that site on the certificate?
- How do you notify clients of scope suspensions or major method changes?
- Can we audit (remote or on-site) according to our vendor policy?
- What proficiency testing or interlaboratory comparisons support this method family?
- How are subcontracted tests disclosed on reports?
If answers are vague, keep shopping.
Multi-site networks: ask “which door receives the box?”
Large networks market a brand. Your risk lives at a receiving dock.
Confirm:
- The accessioning site
- Whether work is transferred internally between sites
- Whether reports clearly state the performing location
- Whether each performing site holds appropriate accreditation for the work performed
A network can be a strength (capacity, redundancy) or a confusion layer. Make it explicit.
How accreditation interacts with quotes and pricing honesty
Accredited competence does not obligate a lab to publish prices. On LabCompare Rx, unclaimed listings stay at Request quote until a lab publishes real rates. That is intentional: invented averages harm trust.
When you evaluate quotes, use accreditation to qualify who is allowed in the bid set, then compare operational fit and price among qualified labs—not the other way around.
Practical workflow
- Define the USP methods you will outsource this year
- Shortlist labs with matching public credentials (directory search)
- Collect scopes before scheduling demos
- Disqualify scope mismatches early
- Pilot with a non-critical or duplicate sample when feasible
- Approve vendor with a dated scope snapshot in the QMS
What accreditation does not replace
Even with a perfect scope PDF, your team still owns:
- Product-specific suitability decisions
- Shipping integrity
- Specification setting and limit justification
- CAPA after failures
- Periodic vendor requalification
Accreditation reduces unknown unknowns about lab competence. It does not automate your quality system.
Training tip for pharmacy buyers
Create a one-page internal job aid:
- “Never approve a lab from a homepage badge alone”
- “Always file certificate + scope”
- “Confirm performing site address”
- “Map USP chapter → scope line item in writing”
That single page prevents a surprising amount of vendor regret.
Bottom line
ISO/IEC 17025 and A2LA accreditation are powerful tools for pharmacy QA—when you verify scope, site, and method fit. Treat accreditation as necessary evidence, then qualify the lab’s communication, logistics, and documentation culture. That combination is what keeps patients safe and inspections uneventful.
LabCompare Rx surfaces accreditation badges and USP capabilities so you can build a smarter shortlist before the first phone call.
Keep reading
Stability & BUD6 min read
Stability Testing and Beyond-Use Dating: How to Use a Contract Lab Wisely
Educational overview of stability testing support for compounding and outsourcing facilities—study design basics, time-point assays, microbiology overlaps, and how to brief a contract laboratory for BUD-related data.
Read guide →
503B & Quality Systems6 min read
503B Outsourcing Facilities: How to Qualify Contract Testing Laboratories
A process guide for 503B quality teams qualifying pharmaceutical CTLs—risk ranking tests, audit questions, quality agreements, data integrity expectations, and ongoing vendor performance management.
Read guide →
Facilities & Utilities6 min read
Pharmaceutical Water Testing for Compounding Facilities: A Practical Outsourcing Guide
How compounding and 503B teams should approach pharmaceutical water testing—conductivity, TOC, endotoxin, bioburden, sampling discipline, and choosing a contract lab for USP water attributes.
Read guide →